Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
批准号:
9320785
负责人:
Karen L Pierce
金额:
$102.62万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-25 至 2019-06-30
关键词:
1 year oldAgeAmericasAutistic DisorderBiological ModelsCDC2 geneCenters for Disease Control and Prevention (U.S.)CharacteristicsChildChildhoodCitiesClinicClinicalDataDatabasesDetectionDevelopmentDevelopmental Delay DisordersDiagnosisDiagnosticEarly DiagnosisEarly InterventionEarly treatmentEnsureEvaluationGuidelinesHabitsHouseholdIncomeLifeLos AngelesMeasuresMedicalModelingNotificationOnline SystemsOutcome MeasureParentsPerformancePhonationProviderReportingResearchRiskScheduleSensitivity and SpecificityServicesSiteSpeedStandardizationSurveysSystemTelephoneTestingToddlerTreatment outcomeUnited States Dept. of Health and Human Servicesbasebrain cellcatalystcheckup examinationclinical practicecohortdata sharingdesigndigitalfollow-upimprovedinnovationmedical specialtiesmemberpediatricianprimary outcomeprogramsprospectivepublic health relevanceresearch studysatisfactionscreeningstandard of caretool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We previously demonstrated that our early intervention model system, which was centered on using the CSBS to screen all babies at the 1-year check-up as standard of care, resulted in a mean age of 12 months for screening, 14 months for evaluation, and 18 months for treatment participation. These are far younger ages than is common in the U.S. Our 3-stage model system, Get SET (S=Screen; E=Evaluate; T=Treat) Early, screened >10,000 1 year olds in our first trial run1 detecting over 100 ASD and other developmental delayed toddlers. We will build on this highly effective model by implementing a new version in two major cities: San Diego and Phoenix; Los Angeles, Irvine, and Phoenix will provide baseline control data. In Phoenix, we test the feasibility of establishing
the Get SET Early model in a city with one of the lowest median incomes and oldest age of first diagnosis in America. In AIM #1, the Screen and Refer Early stage, we will create a Pediatrician Network with 100 members. In San Diego we will utilize our existing Pediatrician Network and test new innovations such as a repeat triple screen at 12, 18, and 24 months to ensure that no toddlers are missed. Speed of referral for evaluation will be compared and contrasted using parent (self) and automatic (referral i- Pad App) options. We will track every toddler with an eventual ASD diagnosis within circumscribed medical groups to determine the true sensitivity and specificity of the screening tool and the percentage of ASD toddlers detected by our model. Anonymous survey data regarding screening habits will be administered to parents and pediatricians. AIM #2 implements the Evaluate and Refer Early stage. Its key attribute is an ASD Early Evaluation Clinic that specializes in the rapid scheduling and evaluation of every referred screened positive toddler. Toddlers will enter the program at the age they fail the screen (i.e., 12, 18 or 24 months) and will be thoroughly diagnostically evaluated and tracked once per year until they turn 3 years. This specialty Clinic is at our Autism Center in San Diego and will be developed at SARRC in Phoenix. Automated versus optional self-referral for treatment will be tested and compared. AIM #3 implements the Treat Early stage. Its key attributes are a network of providers of empirically based treatment and the innovative use of an inexpensive and readily available web-based treatment tracking system to document engagement. Treatment Networks will be created in San Diego and Phoenix. Primary outcome measures include rates and ages of screening and referral, evaluation and referral, and treatment engagement; sustainability across years; diagnostic, clinical and demographic characteristics of subjects; professional and parent satisfaction at each stage. We hypothesize that providing screening tools with clear cut-off scores and guidelines for automatic referral for evaluation and treatment, will result in dramatically lowering mean age of diagnosis and treatment in Phoenix from 4-5 years down to 1-2 years; San Diego will likewise have mean ages of 1-2 years for diagnosis and treatment making them significantly earlier than Los Angeles and Irvine control sites.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Testing the accuracy of eye tracking as a screening tool for ASD in the general population
-
批准号:10638066
-
项目类别:
-
资助金额:$77.84万
-
财政年份:2023
-
负责人:Karen L Pierce
-
依托单位:
1/2-Testing the impact of early screening on the long-term outcomes of children with ASD
-
批准号:10543107
-
项目类别:
-
资助金额:$88.75万
-
财政年份:2020
-
负责人:Karen L Pierce
-
依托单位:
Discovering Eye Tracking Biomarkers of ASD with Diagnostic and Prognostic Power
-
批准号:10063560
-
项目类别:
-
资助金额:$72.27万
-
财政年份:2019
-
负责人:Karen L Pierce
-
依托单位:
Discovering Eye Tracking Biomarkers of ASD with Diagnostic and Prognostic Power
-
批准号:10318939
-
项目类别:
-
资助金额:$71.06万
-
财政年份:2019
-
负责人:Karen L Pierce
-
依托单位:
Discovering Eye Tracking Biomarkers of ASD with Diagnostic and Prognostic Power
-
批准号:10532198
-
项目类别:
-
资助金额:$71.26万
-
财政年份:2019
-
负责人:Karen L Pierce
-
依托单位:
Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
-
批准号:8758746
-
项目类别:
-
资助金额:$109.93万
-
财政年份:2014
-
负责人:Karen L Pierce
-
依托单位:
Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
-
批准号:8916193
-
项目类别:
-
资助金额:$110.7万
-
财政年份:2014
-
负责人:Karen L Pierce
-
依托单位:
Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
-
批准号:9611999
-
项目类别:
-
资助金额:$5.63万
-
财政年份:2014
-
负责人:Karen L Pierce
-
依托单位:
Early Identification of ASD: Translating Eye Tracking into Practice
-
批准号:9297357
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2013
-
负责人:Karen L Pierce
-
依托单位:
Early Identification of ASD: Translating Eye Tracking into Practice
-
批准号:8852183
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:Karen L Pierce
-
依托单位:
Early Identification of ASD: Translating Eye Tracking into Practice
-
批准号:8579445
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2013
-
负责人:Karen L Pierce
-
依托单位:
Early Identification of ASD: Translating Eye Tracking into Practice
-
批准号:9514336
-
项目类别:
-
资助金额:$9.55万
-
财政年份:2013
-
负责人:Karen L Pierce
-
依托单位:
CLINICAL PHENOTYPE: RECRUITMENT AND ASSESMENT CORE
-
批准号:8117637
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2010
-
负责人:Karen L Pierce
-
依托单位:
IMAGING THE AUTISTIC BRAIN BEFORE IT KNOWS IT HAS AUTISM
-
批准号:8117634
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2010
-
负责人:Karen L Pierce
-
依托单位:
IMAGING THE AUTISTIC BRAIN BEFORE IT KNOWS IT HAS AUTISM
-
批准号:7681643
-
项目类别:
-
资助金额:$22.29万
-
财政年份:2008
-
负责人:Karen L Pierce
-
依托单位:
CLINICAL PHENOTYPE: RECRUITMENT AND ASSESMENT CORE
-
批准号:7681646
-
项目类别:
-
资助金额:$41.55万
-
财政年份:2008
-
负责人:Karen L Pierce
-
依托单位:
CLINICAL PHENOTYPE: RECRUITMENT AND ASSESMENT CORE
-
批准号:7292330
-
项目类别:
-
资助金额:$36.8万
-
财政年份:2007
-
负责人:Karen L Pierce
-
依托单位:
Studying the Biology and Behavior of Autism at 1-Year: The Well-Baby Check-Up App
-
批准号:7741258
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2007
-
负责人:Karen L Pierce
-
依托单位:
Studying the Biology and Behavior of Autism at 1-Year: The Well-Baby Check-Up App
-
批准号:7994864
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2007
-
负责人:Karen L Pierce
-
依托单位:
IMAGING THE AUTISTIC BRAIN BEFORE IT KNOWS IT HAS AUTISM
-
批准号:7292322
-
项目类别:
-
资助金额:$26.67万
-
财政年份:2007
-
负责人:Karen L Pierce
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: